iDPP@CLEF 2024 is the final iteration of an evaluation cycle begun in 2022, comprising three challenges aimed at fostering reproducible and comparable evaluation of AI-based approaches for predicting the progression of ALS and MS.
Mar 20, 2024 � iDPP@CLEF run in CLEF 2022 and 2023, offering tasks on the prediction of ALS and MS progression, using retrospective patient clinical data�...
Sep 19, 2024 � iDPP@CLEF 2024 follows the two prior editions, iDPP@CLEF 2022 and 2023. iDPP@CLEF 2022 focused on ALS progression prediction and approaches of�...
Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2024. 5. 2.2 iDPP@CLEF 2023. Similarly to iDPP@CLEF 2022, also iDPP@CLEF 202313 [5, 6] were�...
The goal of iDPP@CLEF is to design and develop an evaluation infrastructure for AI algorithms able to: 1. better describe disease mechanisms; 2. stratify�...
The goal of iDPP CLEF 2024 is to speed up the creation of systems and resources for MS and ALS progression prediction as well as openly share these systems and�...
The goal of iDPP@CLEF is to design and develop an evaluation infrastructure for AI algorithms able to better describe disease mechanisms.
AI tools hold promise for aiding patients and clinicians by identifying the need for intervention and suggesting personalized therapies throughout disease�...
Sep 23, 2024 � Request PDF | On Sep 19, 2024, Giovanni Birolo and others published Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2024�...
Feb 14, 2024 � Explore how iDPP@CLEF challenges leverage AI to predict ALS & MS progression, emphasizing open science, collaboration, & data transparency.